diethylpropion hydrochloride - Profile
What are the generic drug sources for diethylpropion hydrochloride and what is the scope of patent protection?
Diethylpropion hydrochloride
is the generic ingredient in five branded drugs marketed by Lannett Co Inc, Sanofi Aventis Us, Ani Pharms, 3M, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, Watson Labs, and Mpp Pharma, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.Summary for diethylpropion hydrochloride
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 12 |
| NDAs: | 16 |
US Patents and Regulatory Information for diethylpropion hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091680-001 | Oct 24, 2011 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | TENUATE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017669-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ani Pharms | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
